21 NovemberSPS SPotlight Winter Newsletter: Call for Contributions Colleagues, In an attempt to maintain a diverse and current newsletter, we are looking for contrib... read more
21 NovemberInvitation to Publish in the Journal of Pharmacological & Toxicological Methods METHODS IN SAFETY PHARMACOLOGY Guest Editor: Michael K. Pugsley, MSc,PhD, FBPhS, DSP Dear Colleague... read more
21 NovemberHESI Emerging Issues: 2019 Call for Proposals Now Open HESI Emerging Issues The Health and Environmental Sciences Institute (HESI) seeks your suggestions ... read more
21 NovemberInternational 3Rs Prize: Competition Now Open International 3Rs Prize: Competition Now Open Every year the NC3Rs highlights outstanding an... read more
9 November2018 Annual Meeting Images Available for Viewing Thank you for attending the 2018 SPS Annual Meeting! We had a wonderful week and hope you all had s... read more
6 NovemberNew SPS Job Bank Posting: Associate Principal Scientist - Safety and Exploratory Pharmacology (Merck)Employment Opportunities New Postings (as of 11/06/18) Associate Principal Scientist - Safety and E... read more
7 DecemberFDA warns that symptoms of a serious condition affecting the blood cells are not being recognized with the leukemia medicine Idhifa (enasidenib)FDA warns that symptoms of a serious condition affecting the blood cells are not being recognized wi... read more
7 DecemberLa FDA advierte que los síntomas de una afección grave que afecta las células sanguíneas no son reconocidos con el medicamento para la leucemia Idhifa (enasidenib)La FDA advierte que los síntomas de una afección grave que afecta las células sanguíneas no son reco... read more
7 DecemberFDA warns about rare but serious risks of stroke and blood vessel wall tears with multiple sclerosis drug Lemtrada (alemtuzumab)The U.S. Food and Drug Administration (FDA) is warning that rare but serious cases of stroke and tea... read more
7 DecemberLa FDA advierte acerca de los riesgos graves de accidente cerebrovascular y desgarro de las paredes de los vasos sanguíneos con el medicamento para la esclerosis múltiple Lemtrada (alemtuzumab)La FDA advierte acerca de los riesgos graves de accidente cerebrovascular y desgarro de las paredes ... read more
7 DecemberMIT engineers repurpose wasp venom as an antibiotic drugThe venom of insects such as wasps and bees is full of compounds that can kill bacteria. Unfortunate... read more
6 DecemberStatins overprescribed for primary preventionEven healthy people who don't suffer from a cardiovascular disease are prescribed cholesterol-loweri... read more
